Thymoquinone (TQ) demonstrates its neuroprotective effect via an anti-inflammatory action on the Aβ_(1–42)-infused rat model of Alzheimer's disease

References

• Ransohoff RM. How neuroinflammation contributes to neurodegeneration. Science. 2016;353:777–783. doi: 10.1126/science.aag2590
   PubMed Web of Science ®Google Scholar
• Cagnin A, Brooks DJ, Kennedy AM, et al. In vivo measurement of activated microglia in dementia. Lancet. 2001;358:461–467. doi: 10.1016/S0140-6736(01)05625-2
   PubMed Web of Science ®Google Scholar
• Swardfager W, Lanctot K, Rothenburg L, et al. A meta-analysis of cytokines in Alzheimer’s disease. Biol Psychiatry. 2010;68:930–941. doi: 10.1016/j.biopsych.2010.06.012
   PubMed Web of Science ®Google Scholar
• Sahbaz C, Zibandeyeh N, Kurtulmuş A, et al. Role of lymphocyte subsets and T-cell profiles in the immune dysfunction of sSchizophrenia. Biol Psychiatry. 2018;83:S331–S332. doi: 10.1016/j.biopsych.2018.02.853
   Web of Science ®Google Scholar
• Su F, Bai F, Zhang Z. Inflammatory cytokines and Alzheimer’s disease: a review from the perspective of genetic polymorphisms. Neurosci Bull. 2016;32(5):469–480. doi: 10.1007/s12264-016-0055-4
   PubMed Web of Science ®Google Scholar
• Karpenko MN, Vasilishina AA, Gromova EA, et al. Interleukin-1β, interleukin-1 receptor antagonist, interleukin-6, interleukin-10, and tumor necrosis factor-α levels in CSF and serum in relation to the clinical diversity of Parkinson’s disease. Cell Immunol. 2018;327:77–82. doi: 10.1016/j.cellimm.2018.02.011
   PubMed Web of Science ®Google Scholar
• van Vliet EA, Aronica E, Vezzani A, et al. Review: neuroinflammatory pathways as treatment targets and biomarker candidates in epilepsy: emerging evidence from preclinical and clinical studies. Neuropathol Appl Neurobiol. 2018;44(1):91–111. doi: 10.1111/nan.12444
   Web of Science ®Google Scholar
• Schmidt R, Hofer E, Bouwman FH, et al. EFNS-ENS/EAN Guideline on concomitant use of cholinesterase inhibitors and memantine in moderate to severe Alzheimer’s disease. Eur J Neurol. 2015;22:889–898. doi: 10.1111/ene.12707
   PubMed Web of Science ®Google Scholar
• Riedel G, Bergman J, Vanderschuren L, et al. The behavioural pharmacology of dementia. Behav Pharmacol. 2017;27(2 and 3- Special Issue):91–93.
   Google Scholar
• Laver K, Dyer S, Whitehead C, et al. Interventions to delay functional decline in people with dementia: a systematic review of systematic reviews. BMJ Open. 2016;6(4):e010767. DOI:10.1136/bmjopen-2015-010767.
   PubMed Web of Science ®Google Scholar
• Dariani S, Baluchnejadmojarad T, Roghani M. Thymoquinone attenuates astrogliosis, neurodegeneration, mossy fiber sprouting, and oxidative stress in a model of temporal lobe epilepsy. J Mol Neurosci. 2013;51:679–686. doi: 10.1007/s12031-013-0043-3
   PubMed Web of Science ®Google Scholar
• Gokce EC, Kahveci R, Gokce A, et al. Neuroprotective effects of thymoquinone against spinal cord ischemia-reperfusion injury by attenuation of inflammation, oxidative stress, and apoptosis. J Neurosurg Spine. 2016;24:949–959. doi: 10.3171/2015.10.SPINE15612
   PubMed Web of Science ®Google Scholar
• Ullah I, Ullah N, Naseer MI, et al. Neuroprotection with metformin and thymoquinone against ethanol-induced apoptotic neurodegeneration in prenatal rat cortical neurons. BMC Neurosci. 2012;13:11. doi: 10.1186/1471-2202-13-11
   PubMed Web of Science ®Google Scholar
• Alhebshi AH, Gotoh M, Suzuki I. Thymoquinone protects cultured rat primary neurons against amyloid β-induced neurotoxicity. Biochem Biophys Res Commun. 2013;433(4):362–367. doi: 10.1016/j.bbrc.2012.11.139
   PubMed Web of Science ®Google Scholar
• Bargi R, Asgharzadeh F, Beheshti F, et al. The effects of thymoquinone on hippocampal cytokine level, brain oxidative stress status and memory deficits induced by lipopolysaccharide in rats. Cytokine. 2017;96:173–184. doi: 10.1016/j.cyto.2017.04.015
   PubMed Web of Science ®Google Scholar
• Dalli T, Beker M, Terzioglu-Usak S, et al. Thymoquinone activates MAPK pathway in hippocampus of streptozotocin-treated rat model. Biomed Pharmacother. 2018;99:391–401. doi: 10.1016/j.biopha.2018.01.047
   PubMed Web of Science ®Google Scholar
• Terzioglu-Usak S, Negis Y, Karabulut DS, et al. Cellular model of Alzheimer’s disease: Aβ1–42 Peptide induces amyloid deposition and a decrease in topo isomerase IIβ and nurr1 expression. Curr Alzheimer Res. 2017;14(6):636–644. doi: 10.2174/1567205014666170117103217
   PubMed Web of Science ®Google Scholar
• Paxinos G, Watson C. The rat brain in stereotaxiccoordinates. San Diego: Academic Press; 1998.
   Google Scholar
• Vorobyov V, Kaptsov V, Gordon R, et al. Neuroprotective effects of hydrated fullerene C60: cortical and hippocampal EEG interplay in an amyloid-infused rat model of Alzheimer’s disease. J Alzheimers Dis. 2015;45:217–233. doi: 10.3233/JAD-142469
   Web of Science ®Google Scholar
• Barnhart CD, Yang D, Lein PJ, et al. Using the Morris water maze to assess spatial learning and memory in weanling mice. PLoS One. 2015;10(4):e0124521. DOI:10.1371/journal.pone.0124521.
   PubMed Web of Science ®Google Scholar
• Cohen J. The analysis of variance. In: Statistical power analysis for the behavioral sciences. 2nd ed. Hillsdale (NJ): Lawrence Erlbaum Associates; 1988. p. 274–287.
   Google Scholar
• Yirmiya R, Goshen I. Immune modulation of learning, memory, neural plasticity and neurogenesis. Brain Behav. Immun. 2011;25(2):181–213. doi: 10.1016/j.bbi.2010.10.015
   PubMed Web of Science ®Google Scholar
• Chesnokova V, Pechnick RN, Wawrowsky K. Chronic peripheral inflammation, hippocampal neurogenesis, and behavior. Brain Behav Immun. 2016;58:1–8. doi: 10.1016/j.bbi.2016.01.017
   Web of Science ®Google Scholar
• Panche AN, Diwan AD, Chandra SR. Flavonoids: an overview. J Nutr Sci. 2016;5:e47. DOI:10.1017/jns.2016.41.
   PubMed Web of Science ®Google Scholar
• Wang D, Hu M, Li X, et al. Design, synthesis, and evaluation of isoflavone analogs as multifunctional agents for the treatment of Alzheimer’s disease. Eur J Med Chem. 2019;168:207–220. DOI:10.1016/j.ejmech.2019.02.053.
   Web of Science ®Google Scholar
• McNamara CE, Larsen L, Perry NB, et al. Anti-inflammatory sesquiterpene-quinones from the New Zealand sponge Dysidea cf. cristagalli. J Nat Prod. 2005;68:1431–1433. doi: 10.1021/np050171n
   PubMed Web of Science ®Google Scholar
• Sirvanci-Yalabik M, Sehirli AÖ, Utkan T, et al. A Metabolite of arginine, improves learning and memory in streptozotocin-induced Alzheimer’s disease model in rats. Bull Clin Psychopharmacol. 2016;26(4):342–354. doi: 10.5455/bcp.20161121125642
   Google Scholar
• Noshita T, Murayama N, Nakamura S. Effect of nicotine on neuronal dysfunction induced by intracerebroventricular infusion of amyloid-β peptide in rats. Eur Rev Med Pharmacol Sci. 2015;19(2):334–343.
   Web of Science ®Google Scholar
• Campolongo P, Ratano P, Ciotti MT, et al. Systemic administration of substance P recovers beta amyloid-induced cognitive deficits in rat: involvement of Kv potassium channels. PLoS One. 2013;8(11):e78036. doi: 10.1371/journal.pone.0078036
   PubMed Web of Science ®Google Scholar
• Abdel-Zaher AO, Mostafa MG, Farghly HM, et al. Inhibition of brain oxidative stress and inducible nitric oxide synthase expression by thymoquinone attenuates the development of morphine tolerance and dependence in mice. Eur J Pharmacol. 2013;702:62–70. doi: 10.1016/j.ejphar.2013.01.036
   PubMed Web of Science ®Google Scholar
• Majdalawieh AF, Fayyad MW. Immunomodulatory and anti-inflammatory action of Nigella sativa and thymoquinone: a comprehensive review. Int Immunopharmacol. 2015;28:295–304. doi: 10.1016/j.intimp.2015.06.023
   PubMed Web of Science ®Google Scholar
• Zheng C, Zhou XW, Wang JZ. The dual roles of cytokines in Alzheimer's disease: update on interleukins, TNF-α, TGF-β and IFN-γ. Transl Neurodegener. 2016;5:7. doi: 10.1186/s40035-016-0054-4
   PubMed Web of Science ®Google Scholar
• Tau G, Rothman P. Biologic functions of the IFN-gamma receptors. Allergy. 1999;54(12):1233–1251. doi: 10.1034/j.1398-9995.1999.00099.x
   PubMed Web of Science ®Google Scholar
• Huchet R, Bruley-Rosset M, Mathiot C, et al. Involvement of IFN-gamma and transforming growth factor-beta in graft-vs-host reaction-associated immunosuppression. J Immunol. 1993;150:2517–2524.
   PubMed Web of Science ®Google Scholar
• Baruch K, Rosenzweig N, Kertser A, et al. Breaking immune tolerance by targeting Foxp3(+) regulatory T cells mitigates Alzheimer’s disease pathology. Nat Commun. 2015 Aug 18;6:7967. doi: 10.1038/ncomms8967
   PubMed Web of Science ®Google Scholar
• Monsonego A, Imitola J, Petrovic S, et al. Abeta-induced meningoencephalitis is IFN-gamma-dependent and is associated with T cell-dependent clearance of Abeta in a mouse model of Alzheimer’s disease. Proc Natl Acad Sci USA. 2006;103(13):5048–5053. doi: 10.1073/pnas.0506209103
   PubMed Web of Science ®Google Scholar
• Italiani P, Puxeddu I, Napoletano S, et al. Circulating levels of IL-1 family cytokines and receptors in Alzheimer’s disease: new markers of disease progression? J Neuroinflammation. 2018;15(1):342. doi: 10.1186/s12974-018-1376-1
   PubMed Web of Science ®Google Scholar
• Decourt B, Lahiri DK, Sabbagh MN. Targeting tumor necrosis factor alpha for Alzheimer’s disease. Curr Alzheimer Res. 2017;14(4):412–425.
   PubMed Web of Science ®Google Scholar
• Velagapudi R, Kumar A, Bhatia HS, et al. Inhibition of neuroinflammation by thymoquinone requires activation of Nrf2/ARE signalling. Int Immunopharmacol. 2017;48:17–29. doi: 10.1016/j.intimp.2017.04.018
   PubMed Web of Science ®Google Scholar
• Taka E, Mazzio EA, Goodman CB, et al. Anti-inflammatory effects of thymoquinone in activated BV-2 microglial cells. J Neuroimmunol. 2015;286:5–12. doi: 10.1016/j.jneuroim.2015.06.011
   PubMed Web of Science ®Google Scholar
• Rai S, Kamat PK, Nath C, et al. Glial activation and post-synaptic neurotoxicity: the key events in Streptozotocin (ICV) induced memory impairment in rats. Pharmacol Biochem Behav. 2014;117:104–117. doi: 10.1016/j.pbb.2013.11.035
   Web of Science ®Google Scholar
• Masters SL, Mielke LA, Cornish AL, et al. Regulation of interleukin-1beta by interferon-gamma is species specific, limited by suppressor of cytokine signalling 1 and influences interleukin-17 production. EMBO Rep. 2010;11(8):640–646. doi: 10.1038/embor.2010.93
   PubMed Web of Science ®Google Scholar
• Lin Q, Shen F, Zhou Q, et al. Interleukin-1β Disturbs the Proliferation and Differentiation of Neural Precursor Cells in the Hippocampus via Activation of Notch Signaling in Postnatal Rats Exposed to Lipopolysaccharide. ACS Chem Neurosci. 2019;10(5):2560–2575. doi: 10.1021/acschemneuro.9b00051
   PubMed Web of Science ®Google Scholar
• Koo JW. Duman RS IL-1beta is an essential mediator of the antineurogenic and anhedonic effects of stress. Proc Natl Acad Sci USA. 2008;105(2):751–756. doi: 10.1073/pnas.0708092105
   PubMed Web of Science ®Google Scholar
• Wu MD, Hein AM, Moravan MJ, et al. Adult murine hippocampal neurogenesis is inhibited by sustained IL-1β and not rescued by voluntary running. Brain Behav Immun. 2012;26(2):292–300. doi: 10.1016/j.bbi.2011.09.012
   PubMed Web of Science ®Google Scholar
• Wu MD, Montgomery SL, Rivera-Escalera F, et al. Sustained IL-1β expression impairs adult hippocampal neurogenesis independent of IL-1 signaling in nestin+ neural precursor cells. Brain Behav Immun. 2013;32:9–18. doi: 10.1016/j.bbi.2013.03.003
   Web of Science ®Google Scholar
• Beker M, Dallı T, Elibol B. Thymoquinone can improve neuronal survival and promote neurogenesis in rat hippocampal neurons. Mol Nutr Food Res. 2018;62(5):1700768. doi: 10.1002/mnfr.201700768
   Web of Science ®Google Scholar
• Doolaanea AA, Mansor N, Mohd Nor NH, et al. Co-encapsulation of Nigella sativa oil and plasmid DNA for enhanced gene therapy of Alzheimer’s disease. J Microencapsul. 2016;33(2):114–126. doi: 10.3109/02652048.2015.1134689
   PubMed Web of Science ®Google Scholar
• Kosik KS, Duffy LK, Dowling MM, et al. Microtubule-associated protein 2: monoclonal antibodies demonstrate the selective incorporation of certain epitopes into Alzheimer neurofibrillary tangles. Proc Natl Acad Sci USA. 1984;81:7941–7945. doi: 10.1073/pnas.81.24.7941
   PubMed Web of Science ®Google Scholar
• Vaillant AR, Zanassi P, Walsh GS, et al. Signaling mechanisms underlying reversible, activity-dependent dendrite formation. Neuron. 2002;34:985–998. doi: 10.1016/S0896-6273(02)00717-1
   PubMed Web of Science ®Google Scholar
• Taylor-Walker G, Lynn SA, Keeling E, et al. The Alzheimer’s-related amyloid beta peptide is internalised by R28 neuroretinal cells and disrupts the microtubule associated protein 2 (MAP-2). Exp Eye Res. 2016;153:110–121. doi: 10.1016/j.exer.2016.10.013
   PubMed Web of Science ®Google Scholar
• Rak M, Del Bigio MR, Mai S, et al. Dense-core and diffuse Abeta plaques in TgCRND8 mice studied with synchrotron FTIR microspectroscopy. Biopolymers. 2007;87(4):207–217. doi: 10.1002/bip.20820
   Web of Science ®Google Scholar
• D'Andrea MR, Nagele RG. MAP-2 immunolabeling can distinguish diffuse from dense-core amyloid plaques in brains with Alzheimer’s disease. Biotech Histochem. 2002;77(2):95–103. doi: 10.1080/bih.77.2.95.103
   Web of Science ®Google Scholar
• D'Amours D, Desnoyers S, D'Silva I, et al. Poly(ADP-ribosyl)ation reactions in the regulation of nuclear functions. Biochem J. 1999;342(Pt 2):249–268. doi: 10.1042/bj3420249
   PubMed Web of Science ®Google Scholar
• Amé JC, Spenlehauer C, de Murcia G. The PARP superfamily. Bioessays. 2004;26(8):882–893. doi: 10.1002/bies.20085
   PubMed Web of Science ®Google Scholar
• Zeng J, Libien J, Shaik F, et al. Nucleolar PARP-1 expression is decreased in Alzheimer’s disease: consequences for epigenetic regulation of rDNA and cognition. Neural Plast. 2016;2016:8987928. doi: 10.1155/2016/8987928
   Google Scholar
• Hernández AI W, Hu JY, et al. Poly-(ADP-ribose) polymerase-1 is necessary for long-term facilitation in Aplysia. J Neurosci. 2009;29(30):9553–9562. doi: 10.1523/JNEUROSCI.1512-09.2009
   Web of Science ®Google Scholar
• Goldberg S, Visochek L, Giladi E, et al. PolyADP-ribosylation is required for long-term memory formation in mammals. J Neurochem. 2009;111(1):72–79. doi: 10.1111/j.1471-4159.2009.06296.x
   Web of Science ®Google Scholar
• Fontán-Lozano Á, Suárez-Pereira I, Horrillo A, et al. Histone H1 poly[ADP]-ribosylation regulates the chromatin alterations required for learning consolidation. J Neurosci. 2010;30(40):13305–13313. doi: 10.1523/JNEUROSCI.3010-10.2010
   Web of Science ®Google Scholar